$152.620
-0.107 (-0.07%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BLTE Prediction & Forecast by Similar Chart Analysis
Alphio's BLTE stock price prediction model matches the current Belite Bio, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $151.11 (-0.99%). The 1-week path is $153.76 (+0.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Belite Bio, Inc Stock?
Belite Bio Inc is a good buy right now due to its promising clinical developments and strong analyst ratings. The stock is currently priced at $154.49, with analysts projecting a price target of $234 from Mizuho and $245 from H.C. Wainwright, suggesting potential upside of approximately 51.5% and 58.5%, respectively. Additionally, the FDA's priority review for its drug tinlarebant could lead to a significant market opportunity, especially with a projected U.S. launch in 2027. However, the company has reported substantial net losses, with a net income of -28,412,000 USD in Q2 2026, which poses a risk to consider.
BLTE stock price ended at $152.62 on Thursday, after losing -0.07%
Belite Bio, Inc (BLTE) last closed at $152.62, losing -0.07%. These facts feed the 1-day and 1-week BLTE price prediction above.
Forecast Drivers
Belite Bio, Inc (BLTE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BLTE, ranked by similarity.
Seasonality analysis for BLTE
Historically the probability of a positive October return for BLTE is 82.76%. November offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BLTE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $65.23 | $70.88 | $78.93 | -53.56% |
| Nov 2026 | $62.14 | $63.40 | $63.95 | -58.46% |
| Dec 2026 | $65.08 | $68.82 | $77.60 | -54.91% |
In 2026, Belite Bio, Inc (BLTE) is projected to range from $62.14 to $78.93.
Belite Bio, Inc 2026 monthly forecast
In Oct 2026, Belite Bio, Inc is projected to average $70.88, with a low of $65.23 and high of $78.93.
In Nov 2026, Belite Bio, Inc is projected to average $63.40, with a low of $62.14 and high of $63.95.
In Dec 2026, Belite Bio, Inc is projected to average $68.82, with a low of $65.08 and high of $77.60.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.